2025 annual financial data
Ernexa Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -9,319,000 USD and net income was -14,084,000 USD.
Operating cash flow was -7,017,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,319,000 USD
- Net income
- -14,084,000 USD
- Operating cash flow
- -7,017,000 USD